APA (7th ed.) Citation

MS, L., RV, O., M, G., MS, F., & E, W. (2015). Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis. Advances in therapy, 32(3), 228. https://doi.org/10.1007/s12325-015-0191-7

Chicago Style (17th ed.) Citation

MS, Lundblad, Overgaard RV, Göthberg M, Fjording MS, and Watson E. "Clinical Pharmacokinetics of the Anti-interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis." Advances in Therapy 32, no. 3 (2015): 228. https://doi.org/10.1007/s12325-015-0191-7.

MLA (9th ed.) Citation

MS, Lundblad, et al. "Clinical Pharmacokinetics of the Anti-interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis." Advances in Therapy, vol. 32, no. 3, 2015, p. 228, https://doi.org/10.1007/s12325-015-0191-7.